These included gallbladder cancer (HR = 0.35), meningioma (HR = 0.37), pancreatic cancer (HR = 0.41), hepatocellular carcinoma (HR = 0.47), ovarian cancer (HR = 0.52), colorectal cancer (HR = 0.54), multiple myeloma (HR = 0.59), esophageal cancer (HR = 0.60), endometrial cancer (HR = 0.74), and kidney cancer (HR = 0.76)
An approach to spatiotemporally resolve protein interaction networks in living cells
#wellnessjourney #healthtok #healthylifestyle 7 tips for beginners on a GLP-1 If youre new to GLP-1s, these are the tips I wish more people talked about
Take our quick quiz today
When comparing Retatrutide and Tirzepatide, the biggest difference between the two comes down to how many pathways each medication targets
How long do I need to take GLP-1 agonists to see results